CONVERTIBLE NOTES PAYABLE (Details) (USD $)	1 Months Ended			9 Months Ended	12 Months Ended				12 Months Ended		12 Months Ended					12 Months Ended
	Dec. 31, 2013	Mar. 31, 2013	Oct. 31, 2012	Dec. 31, 2013	Mar. 31, 2014	Mar. 31, 2014 Warrant	Mar. 31, 2013	Feb. 07, 2012	Mar. 31, 2012 subsciption agreements [Member]	Feb. 07, 2012 subsciption agreements [Member]	Mar. 31, 2014 Placement Agent Agreement [Member]	Mar. 31, 2014 Placement Agent Agreement [Member] Dawson [Member]	Mar. 31, 2013 Placement Agent Agreement [Member] Dawson [Member]	Mar. 31, 2014 Warrant [Member] Warrant	Mar. 31, 2014 Subordinated Unsecured Convertible Notes Payable Interest At Six Percent Per Annum Payable Semi Annually [Member]	Mar. 31, 2014 Convertible Notes Payable [Member]		Mar. 31, 2013 Convertible Notes Payable [Member]		Feb. 07, 2012 Minimum [Member]	Feb. 07, 2012 Maximum [Member]	Feb. 07, 2012 Per Tranche [Member]	Mar. 31, 2014 Five Tranche [Member] Minimum [Member]	Mar. 31, 2014 Five Tranche [Member] Maximum [Member]
Extinguishment of Debt [Line Items]
Common stock share amount								625,000
Convertible debenture amount								$ 625,000														$ 250,000
Debenture pursuant to Subscription Agreement								693,774
Debenture conversion price																				$ 0.65	$ 1.25
Debt Instrument, Interest Rate, Stated Percentage															6.00%
Debt Instrument, Unamortized Discount		374,592			0	0	374,592									113,341
Debt Instrument, Convertible, Conversion Price					$ 0.45	$ 0.45																	$ 0.65	$ 1.25
Fair value of beneficial conversion feature of convertible notes									177,404
Proceeds From Issuance Of Common Stock			500,000			1,133,250	425,000							1,133,250
Debt Issuance Cost						0	78,458									78,458
Loan Placement Fees						55,000
Derivative, Fair Value, Net		523,458			523,458	523,458	523,458							523,458
Warrants To Purchase Of Common Stock			1,000,000
Free Standing Derivative Value			500,000		500,000	500,000
Proceeds from Issuance or Sale of Equity			445,000
Conversion Shares Issuable To Purchaser Percentage					100.00%	100.00%
Warrants Exercise Price		$ 0.50				$ 0.34								$ 0.34
Conversion of Stock, Shares Issued					733,334	733,334
Debenture Outstanding Amount							330,000
Warrants Granted In Period			1,000,000		11,323,601	11,323,601	1,080,000				294,185	80,000	80,000
Warrants Granted Period In Weighted Exercise Price	0.42		0.70	0.34	0.50	0.50	0.50				0.425	0.625	0.50	0.50		0.70
Minimum Warrants Exercise Price				$ 0.20										$ 0.20
Debt Conversion, Original Debt, Amount							170,000
Convertible Debt																0	[1]	330,000	[1]
Payment Of Costs Related To Purchase Agreement						578,458
Debt Instrument, Increase, Accrued Interest						261,249
Debt Conversion, Converted Instrument, Shares Issued					43,370	43,370	377,778
Stock Issued During Period Value Accrued Interest						$ 37,501	$ 29,500
Common Par Value		$ 0.001			$ 0.001	$ 0.001	$ 0.001			$ 1.00
Number of Common Stock To Be Issued Upon Exercise of Warrants					1,000,000	3,676,472								11,029,416
Warrants Exercise Price		$ 0.50				$ 0.34								$ 0.34

[1] On October 29, 2012, we entered into a Securities Purchase Agreement with two investors providing for the issuance and sale of an aggregate of $500,000 in convertible debentures and warrants to purchase 1,000,000 shares of our common stock, for proceeds to us of $500,000. The financing closed on November 1, 2012. After deducting for fees and expenses, the aggregate net proceeds from the sale of the debentures and warrants was $445,000. The convertible debentures were non-interest bearing and would have matured on November 1, 2014. The convertible debentures were convertible at the investors’ option into shares of the Company’s common stock at an initial conversion price of $0.50 per share, subject to adjustment upon a reclassification or other change in the Company’s outstanding common stock and certain distributions to all holders of the Company’s common stock. The Company analyzed the conversion feature of the convertible debentures and determined that they called for a fixed number of shares upon their conversion, and were indexed to the Company’s own stock, and were therefore, not subject to derivative accounting. The Company also analyzed whether a beneficial conversion feature existed at the date of issuance of the convertible debentures and determined that no beneficial conversion feature existed on the conversion feature of the convertible debentures upon issuance date as their conversion price equaled the market price of the Company’s stock. During the year ended March 31, 2013, $170,000 of the debentures were converted into 377,778 shares of common stock, and the remaining balance due on these debentures at March 31, 2013 was $330,000. All of the $330,000 remaining balance of the debentures was converted into 733,334 shares of our common stock during the fiscal year ended March 31, 2014 based on the adjusted conversion price of $0.45 per share. Each of the investors was also issued a warrant to purchase up to a number of shares of the Company’s common stock equal to 100% of the shares initially issuable to such investor upon conversion of the convertible debenture issued pursuant to the Securities Purchase Agreement, totaling up to 1,000,000 shares of common stock. The warrants had an initial exercise price of $0.70 per share, were exercisable immediately upon issuance and had a term of exercise equal to five years. The Company also issued warrants to purchase up to 80,000 shares of the Company’s common stock to its placement agent related to the financing that had an initial exercise price of $0.625 per share. On March 6, 2013, the exercise price of all the warrants was reduced to $0.50. On June 28, 2013, the exercise price of all of the warrants was further reduced to $0.34. During the year ended March 31, 2014, the investors exercised all of their warrants and acquired 1,000,000 shares of the Company’s common stock at the then-effective exercise price of $0.34 per share. As of March 31, 2014, all of the placement agent’s warrants remained outstanding. Each of the warrants included an anti-dilution provision that allows for the automatic reset of the exercise price upon any future sale of the Company’s common stock, warrants, options, convertible debt or any other equity-linked securities at an issuance, exercise or conversion price below the current exercise price of the warrants issued with the convertible debentures, provided that the exercise price shall not be reduced to less than $0.20 per share. The Company considered the current FASB guidance of “Determining Whether an Instrument Indexed to an Entity’s Own Stock” and determined that the exercise price of the warrants was not a fixed amount because it is subject to fluctuation based on the occurrence of future offerings or events. As a result, the Company determined that the warrants were not considered indexed to the Company’s own stock and characterized the initial fair value of these warrants as a derivative liability upon issuance. The Company determined the aggregate initial fair value of the warrants issued to investors and the placement agent to be $523,458 upon issuance. These amounts were determined by management using a using a probability weighted average Black-Scholes Merton option pricing model. The total cost to the Company of the transactions related to the Securities Purchase Agreement was $578,458, which included placement fees and expenses of $55,000 and the fair value of the warrant derivative of $523,458. To account for these costs, the Company recorded a valuation discount of $500,000 upon issuance, and the incremental cost of $78,458 over the face amount of the convertible debentures was recorded as a financing cost during the year ended March 31, 2013. The Company was amortizing the valuation discount to interest expense over the life of the convertible debentures. As of March 31, 2013, the balance of the unamortized discount was $261,249. During the year ended March 31, 2014, the Company recognized interest expense of $261,249 relating to the amortization of the remaining unamortized debt discount as all of the debentures were converted into shares of our common stock.